Here's Why You Should Buy Align Technology (ALGN) Stock Now
https://www.zacks.com/stock/news/2274303/here-s-why-you-should-buy-align-technology-algn-stock-now?cid=CS-ZC-FT-analyst_blog|rank_focused-2274303
May 15, 2024 - Investors are optimistic about Align Technology (ALGN) led by expansion in new geographies and upbeat guidance.
0
Philips' (PHG) Gets FDA Recall for Trilogy Ventilator Glitch
https://www.zacks.com/stock/news/2273683/philips-phg-gets-fda-recall-for-trilogy-ventilator-glitch?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2273683
May 14, 2024 - Philips' (PHG) software update for Trilogy Evo ventilators is set to mitigate a possible power malfunction and gets FDA Class I recall identification, as it may cause serious harm.
0
AMN Healthcare (AMN) Q1 Earnings and Revenues Beat Estimates
https://www.zacks.com/stock/news/2272310/amn-healthcare-amn-q1-earnings-and-revenues-beat-estimates?cid=CS-ZC-FT-analyst_blog|earnings_article-2272310
May 10, 2024 - AMN Healthcare's (AMN) dismal results in the majority of its segments led to a soft overall first-quarter performance.
0
QuidelOrtho (QDEL) Q1 Earnings Beat Estimates, Margins Fall
https://www.zacks.com/stock/news/2271721/quidelortho-qdel-q1-earnings-beat-estimates-margins-fall?cid=CS-ZC-FT-analyst_blog|earnings_article-2271721
May 09, 2024 - QuidelOrtho's (QDEL) first-quarter results reflect growth in revenues, excluding the COVID-19 revenue impact.
0
Nevro's (NVRO) Q1 Earnings and Sales Beat Estimates, Margins Up
https://www.zacks.com/stock/news/2270793/nevro-s-nvro-q1-earnings-and-sales-beat-estimates-margins-up?cid=CS-ZC-FT-analyst_blog|earnings_article-2270793
May 08, 2024 - Nevro's (NVRO) first-quarter earnings and revenues surpass their respective Zacks Consensus Estimate. The company incurs a loss in the operating level.
0
Masimo (MASI) Q1 Earnings Beat Estimates, '24 EPS View Up
https://www.zacks.com/stock/news/2270706/masimo-masi-q1-earnings-beat-estimates-24-eps-view-up?cid=CS-ZC-FT-analyst_blog|earnings_article-2270706
May 08, 2024 - Masimo's (MASI) Q1 healthcare revenues reflect strong sensor orders, which were completely offset by lower capital equipment purchases. Sensor production in Malaysia is likely to improve Healthcare gross margin.
0
Quest Diagnostics (DGX) Grows in Digital Pathology With New Deal
https://www.zacks.com/stock/news/2269766/quest-diagnostics-dgx-grows-in-digital-pathology-with-new-deal?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2269766
May 07, 2024 - Quest Diagnostics' (DGX) pathology laboratories nationwide are set to get a boost with PathAI's AISight digital pathology image management system.
0
Hologic's (HOLX) Q2 Earnings Beat Estimates, 2024 View Up
https://www.zacks.com/stock/news/2268227/hologic-s-holx-q2-earnings-beat-estimates-2024-view-up?cid=CS-ZC-FT-analyst_blog|earnings_article-2268227
May 03, 2024 - Hologic's (HOLX) GYN Surgical Q2 performance was driven by strong results from MyoSure and Fluent Fluid Management.
0
Teleflex (TFX) Q1 Earnings Beat Estimates, Margins Rise
https://www.zacks.com/stock/news/2268160/teleflex-tfx-q1-earnings-beat-estimates-margins-rise?cid=CS-ZC-FT-analyst_blog|earnings_article-2268160
May 03, 2024 - Teleflex's (TFX) first-quarter 2024 results reflect growth across the majority of the company's product families in EMEA.
0
Reasons to Retain Quest Diagnostics (DGX) Stock for Now
https://www.zacks.com/stock/news/2267265/reasons-to-retain-quest-diagnostics-dgx-stock-for-now?cid=CS-ZC-FT-analyst_blog|rank_focused-2267265
May 02, 2024 - Investors are optimistic about Quest Diagnostics (DGX) on strong legacy business growth.
0
Page 1>